TherapeuticsMD is a pharmaceutical royalty company, primarily collecting royalties from its licensees. Co. out-licenses its products and collects royalties, after granting a license to commercialize its IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD® and vitaMedMD® brands in the US and its possessions and territories and assigning its license to commercialize ANNOVERA in the US and its possessions and territories to Mayne Pharma LLC. Co. also has license agreements with partners to commercialize IMVEXXY and BIJUVA outside of the US. We show 54 historical shares outstanding datapoints in our TXMD shares outstanding history coverage, used to compute TXMD market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing TXMD market cap history over the course of time is important for investors
interested in comparing TXMD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of TXMD versus a peer is one thing; comparing
TXMD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like TXMD can fluctuate over the course of history.
With this page we aim to empower investors researching TXMD by allowing them to research the TXMD market cap history. |
Free TXMD Email Alerts:
Video: The Importance of Market Cap
